Parallel Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,073
Closed -$367K 2837
2020
Q1
$367K Buy
2,073
+868
+72% +$163K 0.03% 311
2019
Q4
$230K Buy
1,205
+19
+2% +$3.43K 0.02% 465
2019
Q3
$200K Buy
1,186
+714
+151% +$116K 0.02% 478
2019
Q2
$79K Sell
472
-212
-31% -$29.4K 0.01% 745
2019
Q1
$100K Sell
684
-258
-27% -$37.4K 0.01% 614
2018
Q4
$125K Sell
942
-378
-29% -$62K 0.02% 471
2018
Q3
$252K Buy
1,320
+87
+7% +$16K 0.03% 333
2018
Q2
$205K Buy
1,233
+319
+35% +$51.2K 0.03% 343
2018
Q1
$154K Sell
914
-69
-7% -$11.6K 0.02% 396
2017
Q4
$161K Buy
983
+27
+3% +$4.84K 0.03% 373
2017
Q3
$167K Sell
956
-187
-16% -$43.5K 0.03% 354
2017
Q2
$288K Buy
1,143
+198
+21% +$46.5K 0.05% 254
2017
Q1
$230K Buy
945
+102
+12% +$23.8K 0.05% 272
2016
Q4
$177K Buy
+843
New +$175K 0.04% 270

Other funds holding AGN

Parallel Advisors's AGN Position: Q2 2020 in Review

Parallel Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,073 shares — an estimated $367K sold.

Parallel Advisors first reported a position in AGN in Q4 2016 and held it in 14 quarters. The position peaked at $367K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Parallel Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Parallel Advisors sold 2,073 Allergan plc shares in Q2 2020, an estimated $367K.
  • Parallel Advisors first reported a position in Allergan plc in Q4 2016 and held it in 14 quarters.
  • Parallel Advisors's Allergan plc position peaked at $367K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Parallel Advisors's 13F filing for Q2 2020, filed 16 Jul 2020.